National Center for Medical Genomics (NCLG)
- Project Identification
- LM2018132
- Project Period
- 1/2020 - 12/2022
- Investor / Pogramme / Project type
-
Ministry of Education, Youth and Sports of the CR
- Large Infrastructures for Research, Development and Innovation
- MU Faculty or unit
- Central European Institute of Technology
- Cooperating Organization
-
Charles University
- Responsible person prof. Ing. Stanislav Kmoch, CSc.
National Centre of Medical Genomics (NCMG) is the only research infrastructure in the Roadmap for Large Research, Development and Innovation Infrastructures of the Czech Republic focused on medical genomics. Local (national) genomic infrastructure is the only way how we can unite genomic experts, clinicians, scientist, patients and industry to study, identify and understand causes of individual and population specific diseases. Interdisciplinary collaboration will increase competitiveness of Czech biomedical science and our recent results clearly document, that this approach leads to significant discoveries (e.g. identification of causal genes and elucidation of molecular basis of > 20 human genetic diseases, leukemia, aspergillosis, inherited neurodegenerative and neuromuscular diseases, skin diseases and metabolics diseases), may attract foreign investigators to use the expertize and may have economic impact (new diagnostic products introduced on the market thanks to collaboration of MU and company Generi BioTech). Infrastructure is also important for education and training of new generation of scientists, computing specialists, bioinformaticians, statisticians, instrument operators, clinical genomicists and clinicians. All participating groups are involved in pregraduate and postgraduate education as well as in organization of specialised training programs and courses and organisation of workshops and symposia.
Sustainable Development Goals
Masaryk University is committed to the UN Sustainable Development Goals, which aim to improve the conditions and quality of life on our planet by 2030.
Publications
Total number of publications: 61
2023
-
16S rRNA gene primer choice impacts off-target amplification in human gastrointestinal tract biopsies and microbiome profiling
Nature Scientific Reports, year: 2023, volume: 13, edition: 1, DOI
-
Catechol-O-methyl transferase suppresses cell invasion and interplays with MET signaling in estrogen dependent breast cancer
Scientific Reports, year: 2023, volume: 13, edition: 1, DOI
-
Cerebral organoids derived from patients with Alzheimer´s disease with PSEN1/2 mutations have defective tissue patterning and altered development
CELL REPORTS, year: 2023
-
Cílená detekce somatických mutací u pacientů s ameloblastomem: série případů
Year: 2023, type: Conference abstract
-
Desmocollin-1 is associated with pro-metastatic phenotype of luminal A breast cancer cells and is modulated by parthenolide
Cellular & Molecular Biology Letters, year: 2023, volume: 28, edition: 1, DOI
-
Enrichment of human nasopharyngeal bacteriome with bacteria from dust after short-term exposure to indoor environment: a pilot study
BMC Microbiology, year: 2023, volume: 23, edition: 1, DOI
-
Evropská iniciativa 1+ Milion genomů – mezinárodní projekt zaměřený na sdílení genomických dat.
Year: 2023, type: Conference abstract
-
Glioblastoma and cerebral organoids: development and analysis of an in vitro model for glioblastoma migration
MOLECULAR ONCOLOGY, year: 2023, volume: 17, edition: 4, DOI
-
Long non-coding RNAs enable precise diagnosis and prediction of early relapse after nephrectomy in patients with renal cell carcinoma
Journal of cancer research and clinical oncology, year: 2023, DOI
-
Myeloid lineage cells evince distinct steady-state level of certain gene groups in dependence on hereditary angioedema severity
FRONTIERS IN GENETICS, year: 2023, volume: 14, edition: July 2023, DOI